Yantai Lannacheng Biotechnology

Yijing, Shanxi, China

Company profile

Yantai Lannacheng Biotechnology company profile

Yantai Lannacheng Biotechnology is a biotech business that focuses on the building class I diagnosis and therapy integrated novel tumor nuclear medication research and development platform.and therapy integrated novel tumor nuclear medication research and development platform.

Business identity

Website: https://www.dc-lnc.com
Operating status: Active
Company type: For Profit
Employee range: 00001-00010 employees
Founded: 2021-01-01

Headquarters

Headquarters: Yijing, Shanxi, China
Country code: CN
Continent: Asia

Capital profile

Funding and company signals

Funding stage: Late Stage Venture
Funding rounds: 3
Total equity funding: $103.8M
Last funding: Series C / $41.8M / 2025-07-20
Last equity funding: Series C / $41.8M
Investors: 12
Lead investors: 1
Articles: 16

Categories and groups

Biopharma Biotechnology Wellness Biotechnology Health Care Science and Engineering

Founders and investors

Lead investors

Shenzhen Capital Group

Investors

China Cinda Asset ManagementQianhai Fund of FundsReal Power CapitalShenzhen Capital GroupYuanhe Capital

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.